Unraveling the expression of the oncogene YAP1, a Wnt/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients-Reference-Cited by-同舟云学术

Unraveling the expression of the oncogene YAP1, a Wnt/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients

Published:2016-10-01 Issue:51 Volume:7 Page:84634-84644
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Abduch Rafael H.¹,Bueno Ana Carolina¹,Leal Leticia F.¹,Cavalcanti Marcelo M.¹,Gomes Débora C.²,Brandalise Silvia R.³,Masterallo Maria J.³,Yunes José A.³,Martinelli Carlos E.¹,Tone Luiz G.¹,Tucci Silvio⁴,Molina Carlos A.F.⁴,Ramalho Fernando S.⁵,Moreira Ayrton C.⁶,Cardinalli Izilda A.³,Scrideli Carlos A.¹,Ramalho Leandra N.Z.⁵,de Castro Margaret⁶,Antonini Sonir R.¹

Affiliation:

1. Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil

2. Federal University of Uberlandia, Brazil

3. Boldrini Children's Center, Campinas, Brazil

4. Department of Surgery, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil

5. Department of Pathology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil

6. Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low PRKAB2 Expression Is Associated with Poor Outcomes in Pediatric Adrenocortical Tumors, and Treatment with Rottlerin Increases the PRKAB2 Level and Inhibits Tumorigenic Aspects in the NCI-H295R Adrenocortical Cancer Cell Line;Cancers;2024-03-08

2. Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma;Frontiers in Endocrinology;2024-01-09

3. Analysis of YAP1 Gene as a Potential Immune-Related Biomarker and Its Relationship with the TAZ Expression;IFMBE Proceedings;2024

4. Vitamin D receptor activation is a feasible therapeutic target to impair adrenocortical tumorigenesis;Molecular and Cellular Endocrinology;2022-12

5. Vitamin D receptor hypermethylation as a biomarker for pediatric adrenocortical tumors;European Journal of Endocrinology;2022-05-01